Key HighlightsMotixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease and beta-thalassemia enabling accelerated access to gene therapies73% ...
Key HighlightsMotixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease and beta-thalassemia enabling accelerated access to gene therapies73% ...
Being a doctor with sickle cell disease helps columnist Oluwatosin Adesoye relate to patients, but it also presents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results